Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis.
Lockwood CM, Merker JD, Bain E, Compton C, Grossman RL, Johann D, Jones F, Jones G, Kreifels M, LeBlang S, Lee JSH, Lyle J, Martini JF, Saunders L, Scher H, Somiari S, Stewart M, Vinson J, Leiman LC. Lockwood CM, et al. Among authors: bain e. Clin Pharmacol Ther. 2024 Aug 20. doi: 10.1002/cpt.3416. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 39164947 Review.
Heparin Dosing During Percutaneous Coronary Intervention and Obesity.
Kreutz RP, Leon IG, Bain ER, George B, Phookan S, Prakash A, Sinha AK, Breall JA, Zenisek JR, Frick KA, Jaradat ZA, Abu Romeh IS, O'Leary B, Kalra A, Kumar A, Lee MS, von der Lohe E. Kreutz RP, et al. Among authors: bain er. J Cardiovasc Pharmacol. 2024 Mar 1;83(3):251-257. doi: 10.1097/FJC.0000000000001525. J Cardiovasc Pharmacol. 2024. PMID: 38086077
Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.
Newhouse R, Nelissen E, El-Shakankery KH, Rogozińska E, Bain E, Veiga S, Morrison J. Newhouse R, et al. Among authors: bain e. Cochrane Database Syst Rev. 2023 Jul 5;7(7):CD006910. doi: 10.1002/14651858.CD006910.pub3. Cochrane Database Syst Rev. 2023. PMID: 37407274 Free PMC article. Review.
A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.
Vize CJ, Kim SK, Matthews T, Macsai M, Merrell R, Hsu S, Kundu MG, Yoon J, Kennedy E, Pai M, Bain E, Lassman AB, Moazami G. Vize CJ, et al. Among authors: bain e. Ophthalmic Res. 2023;66(1):1030-1043. doi: 10.1159/000531142. Epub 2023 May 31. Ophthalmic Res. 2023. PMID: 37257422 Free PMC article. Clinical Trial.
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Lassman AB, Pugh SL, Wang TJC, Aldape K, Gan HK, Preusser M, Vogelbaum MA, Sulman EP, Won M, Zhang P, Moazami G, Macsai MS, Gilbert MR, Bain EE, Blot V, Ansell PJ, Samanta S, Kundu MG, Armstrong TS, Wefel JS, Seidel C, de Vos FY, Hsu S, Cardona AF, Lombardi G, Bentsion D, Peterson RA, Gedye C, Bourg V, Wick A, Curran WJ, Mehta MP. Lassman AB, et al. Among authors: bain ee. Neuro Oncol. 2023 Feb 14;25(2):339-350. doi: 10.1093/neuonc/noac173. Neuro Oncol. 2023. PMID: 35849035 Free PMC article. Clinical Trial.
153 results